Health Information Management

Digest the new mandatory reporting requirements for ESA administration as of April 7

Briefings on APCs, March 1, 2008

In January, CMS published three transmittals that present sizeable operational challenges when billing for erythropoietin stimulating agents (ESA) drugs, such as EPO, DPO, Epogen, Procrit, and Aranesp. The transmittals include: Transmittal 1412, Change Request 5699 Transmittal 1413, Change Request 5818 Transmittal 80, Change Request 5818 Although facilities that provide end-stage renal disease (ESRD) treatments are already familiar with these guidelines, other hospitals may find that the coverage and billing requirements are unfamiliar and difficult to implement.

Post a Comment





Please enter your comment below:


Please enter the text below:

    Briefings on APCs
  • Briefings on APCs

    Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...

  • HIM Briefings

    Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...

  • Briefings on Coding Compliance Strategies

    Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...

  • Briefings on HIPAA

    How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...

  • APCs Insider

    This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...

Most Popular